News
1 in 10 Americans Has Used GLP-1 Drugs For Weight Loss, Survey Says
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 drug for weight loss, a new survey by the RAND research group reveals. About 12% say they’ve tried GLP-1 drugs, like Ozempic, Wegovy or Zepbound, with rates of use highest among people ages 50 to 64, survey results show.
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 shots.
Flow Space on MSN3d
Lizzo's Weight Loss Reveal Sparks Key GLP-1 AdviceFor example, on a recent episode of the Just Trish podcast, singer, songwriter and rapper Lizzo explained that she tried Ozempic and other GLP-1 drugs at one point in her “weight release” journey but ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback